{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:37:46Z","timestamp":1791286666485,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR049794"],"award-info":[{"award-number":["AR049794"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007263","name":"Astellas Foundation for Research on Metabolic Disorders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009024","name":"Exploratory Research for Advanced Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008519","name":"University of Arkansas for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008519","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020492","name":"Translational Research Institute Australia","doi-asserted-by":"publisher","award":["UL1 RR029884"],"award-info":[{"award-number":["UL1 RR029884"]}],"id":[{"id":"10.13039\/501100020492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.bone.2012.08.121","type":"journal-article","created":{"date-parts":[[2012,8,23]],"date-time":"2012-08-23T01:00:21Z","timestamp":1345683621000},"page":"258-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":208,"title":["Osteocyte control of osteoclastogenesis"],"prefix":"10.1016","volume":"54","author":[{"given":"Charles A.","family":"O'Brien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takayanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2012.08.121_bb0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bone.2012.08.121_bb0010","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bone.2012.08.121_bb0015","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","article-title":"Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein","volume":"68","author":"Brunkow","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bone.2012.08.121_bb0020","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bone.2012.08.121_bb0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jmg.39.2.91","article-title":"Identification of a 52kb deletion downstream of the SOST gene in patients with van Buchem disease","volume":"39","author":"Balemans","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.bone.2012.08.121_bb0030","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajmg.10401","article-title":"A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12\u2013q21 is associated with van Buchem disease in the Dutch population","volume":"110","author":"Staehling-Hampton","year":"2002","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.bone.2012.08.121_bb0035","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20031454","article-title":"Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist","volume":"199","author":"Van Bezooijen","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.bone.2012.08.121_bb0040","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nm.2452","article-title":"Evidence for osteocyte regulation of bone homeostasis through RANKL expression","volume":"17","author":"Nakashima","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.bone.2012.08.121_bb0045","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nm.2448","article-title":"Matrix-embedded cells control osteoclast formation","volume":"17","author":"Xiong","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.bone.2012.08.121_bb0050","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1210\/endo-123-5-2600","article-title":"Osteoblastic cells are involved in osteoclast formation","volume":"123","author":"Takahashi","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2012.08.121_bb0055","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/345442a0","article-title":"The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene","volume":"345","author":"Yoshida","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bone.2012.08.121_bb0060","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bone.2012.08.121_bb0065","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.bone.2009.08.050","article-title":"Control of RANKL gene expression","volume":"46","author":"O'Brien","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.bone.2012.08.121_bb0070","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W","article-title":"Involvement of receptor activator of nuclear factor \u03ba B ligand\/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis","volume":"43","author":"Takayanagi","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bone.2012.08.121_bb0075","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1210\/endo.141.12.7840","article-title":"The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated","volume":"141","author":"Gori","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2012.08.121_bb0080","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1359\/jbmr.2002.17.11.2068","article-title":"MLO-Y4 osteocyte-like cells support osteoclast formation and activation","volume":"17","author":"Zhao","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2012.08.121_bb0085","doi-asserted-by":"crossref","first-page":"19301","DOI":"10.1074\/jbc.274.27.19301","article-title":"STAT3 activation in stromal osteoblastic cells is required for induction of the receptor activator of NF-\u03baB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D-3 or parathyroid hormone","volume":"274","author":"O'Brien","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2012.08.121_bb0090","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1359\/jbmr.2000.15.7.1321","article-title":"Prostaglandin E-2 induces expression of receptor activator of nuclear factor-\u03baB ligand\/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency","volume":"15","author":"Kanematsu","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2012.08.121_bb0095","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bone.2012.08.121_bb0100","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1359\/jbmr.071025","article-title":"Murine and chicken chondrocytes regulate osteoclastogenesis by producing RANKL in response to BMP2","volume":"23","author":"Usui","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2012.08.121_bb0105","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S8756-3282(99)00214-8","article-title":"Localization of RANKL (Receptor activator of NF\u03baB ligand) mRNA and protein in skeletal and extraskeletal tissues","volume":"25","author":"Kartsogiannis","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.bone.2012.08.121_bb0110","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nri2062","article-title":"Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems","volume":"7","author":"Takayanagi","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bone.2012.08.121_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.tem.2012.05.005","article-title":"New insights into osteoclastogenic signaling mechanisms","author":"Nakashima","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.bone.2012.08.121_bb0120","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1101\/gad.13.8.1015","article-title":"TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling","volume":"13","author":"Lomaga","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.bone.2012.08.121_bb0125","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2443.1999.00265.x","article-title":"Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice","volume":"4","author":"Naito","year":"1999","journal-title":"Genes Cells"},{"key":"10.1016\/j.bone.2012.08.121_bb0130","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.0105-2896.2005.00332.x","article-title":"Fos\/AP-1 proteins in bone and the immune system","volume":"208","author":"Wagner","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bone.2012.08.121_bb0135","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/nm1197-1285","article-title":"Osteopetrosis in mice lacking nf-\u03ba-b1 and nf\u03bab2","volume":"3","author":"Iotsova","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.bone.2012.08.121_bb0140","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1101\/gad.11.24.3482","article-title":"Requirement for nf\u03bab in osteoclast and b-cell development","volume":"11","author":"Franzoso","year":"1997","journal-title":"Genes Dev"},{"key":"10.1016\/j.bone.2012.08.121_bb0145","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm1515","article-title":"Regulation of osteoclast differentiation and function by the CaMK-CREB pathway","volume":"12","author":"Sato","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.bone.2012.08.121_bb0150","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1242\/jcs.00082","article-title":"JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms","volume":"115","author":"David","year":"2002","journal-title":"J Cell Sci"},{"key":"10.1016\/j.bone.2012.08.121_bb0155","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev Cell"},{"key":"10.1016\/j.bone.2012.08.121_bb0160","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20051150","article-title":"Autoamplification of NFATc1 expression determines its essential role in bone homeostasis","volume":"202","author":"Asagiri","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.bone.2012.08.121_bb0165","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1172\/JCI35711","article-title":"NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism","volume":"118","author":"Aliprantis","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2012.08.121_bb0170","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature02444","article-title":"Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis","volume":"428","author":"Koga","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bone.2012.08.121_bb0175","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.cell.2007.12.037","article-title":"Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals","volume":"132","author":"Shinohara","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bone.2012.08.121_bb0180","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1172\/JCI45913","article-title":"OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice","volume":"121","author":"Barrow","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2012.08.121_bb0185","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.320","article-title":"The amazing osteocyte","volume":"26","author":"Bonewald","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2012.08.121_bb0190","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.bone.2004.05.023","article-title":"Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation","volume":"35","author":"Sutherland","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.bone.2012.08.121_bb0195","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1359\/jbmr.090411","article-title":"Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt\/\u03b2-catenin signaling","volume":"24","author":"Lin","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2012.08.121_bb0200","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength","volume":"23","author":"Li","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2012.08.121_bb0205","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.cmet.2007.05.001","article-title":"Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction","volume":"5","author":"Tatsumi","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.bone.2012.08.121_bb0210","doi-asserted-by":"crossref","first-page":"e2942","DOI":"10.1371\/journal.pone.0002942","article-title":"Control of bone mass and remodeling by PTH receptor signaling in osteocytes","volume":"3","author":"O'Brien","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2012.08.121_bb0215","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/jbmr.304","article-title":"PTH receptor signaling in osteocytes governs periosteal bone formation and intra-cortical remodeling","volume":"26","author":"Rhee","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2012.08.121_bb0220","doi-asserted-by":"crossref","DOI":"10.1210\/er.2011-1060","article-title":"Sclerostin and dickkopf-1 as therapeutic targets in bone diseases","author":"Ke","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bone.2012.08.121_bb0225","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1128\/MCB.01428-09","article-title":"Osteocyte Wnt\/\u03b2-catenin signaling is required for normal bone homeostasis","volume":"30","author":"Kramer","year":"2010","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bone.2012.08.121_bb0230","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF02409454","article-title":"Role of osteoblasts in hormonal control of bone resorption\u2014a hypothesis","volume":"33","author":"Rodan","year":"1981","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2012.08.121_bb0235","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","article-title":"Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families","volume":"20","author":"Suda","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bone.2012.08.121_bb0240","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF01771319","article-title":"Isolated chick osteocytes stimulate formation and bone-resorbing activity of osteoclast-like cells","volume":"13","author":"Tanaka","year":"1995","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.bone.2012.08.121_bb0245","doi-asserted-by":"crossref","first-page":"13835","DOI":"10.1073\/pnas.95.23.13835","article-title":"Dissociation between bone resorption and bone formation in osteopenic transgenic mice","volume":"95","author":"Corral","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bone.2012.08.121_bb0250","doi-asserted-by":"crossref","first-page":"12654","DOI":"10.1074\/jbc.M806628200","article-title":"Commitment to the osteoblast lineage is not required for RANKL gene expression","volume":"284","author":"Galli","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2012.08.121_bb0255","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00441-005-0066-3","article-title":"Isolated primary osteocytes express functional gap junctions in vitro","volume":"323","author":"Gu","year":"2006","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.bone.2012.08.121_bb0260","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.bone.2009.06.010","article-title":"Identification of differentially expressed genes between osteoblasts and osteocytes","volume":"45","author":"Paic","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bone.2012.08.121_bb0265","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/154405910708600404","article-title":"DMP1-targeted Cre expression in odontoblasts and osteocytes","volume":"86","author":"Lu","year":"2007","journal-title":"J Dent Res"},{"key":"10.1016\/j.bone.2012.08.121_bb0270","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1242\/dev.02480","article-title":"Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors","volume":"133","author":"Rodda","year":"2006","journal-title":"Development"},{"key":"10.1016\/j.bone.2012.08.121_bb0275","doi-asserted-by":"crossref","first-page":"44005","DOI":"10.1074\/jbc.M208265200","article-title":"Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization","volume":"277","author":"Zhang","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2012.08.121_bb0280","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.matbio.2008.07.001","article-title":"Specific expression of Cre recombinase in hypertrophic cartilage under the control of a BAC-Col10a1 promoter","volume":"27","author":"Gebhard","year":"2008","journal-title":"Matrix Biol"},{"key":"10.1016\/j.bone.2012.08.121_bb0285","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/jcb.10623","article-title":"In vivo administration of 1,25-dihydroxyvitamin D-3 suppresses the expression of RANKL mRNA in bone of thyroparathyroidectomized rats constantly infused with PTH","volume":"90","author":"Ueno","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bone.2012.08.121_bb0290","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1210\/en.2003-1695","article-title":"Parathyroid hormone-related peptide is required for increased trabecular bone volume in parathyroid hormone-null mice","volume":"145","author":"Miao","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2012.08.121_bb0295","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bone.2012.08.121_bb0300","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1210\/endo.140.8.6887","article-title":"Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation","volume":"140","author":"Lee","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2012.08.121_bb0305","doi-asserted-by":"crossref","first-page":"48868","DOI":"10.1074\/jbc.M208494200","article-title":"Parathyroid hormone stimulates receptor activator of NF\u03baB ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein","volume":"277","author":"Fu","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2012.08.121_bb0310","first-page":"S16","article-title":"PTH\/PTHrP (PPR) receptor signaling in osteocytes regulate bone development in temporal manner","volume":"26","author":"Saini","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2012.08.121_bb0315","first-page":"S16","article-title":"Conditional deletion of the parathyroid hormone (PTH) receptor 1 from osteocytes results in decreased bone resorption and a progressive increase in cancellous bone mass","volume":"26","author":"Tu","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2012.08.121_bb0320","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1128\/MCB.00356-06","article-title":"Parathyroid hormone controls receptor activator of NF-\u03baB ligand gene expression via a distant transcriptional enhancer","volume":"26","author":"Fu","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bone.2012.08.121_bb0325","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1128\/MCB.00353-06","article-title":"Activation of receptor activator of NF-\u03baB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers","volume":"26","author":"Kim","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bone.2012.08.121_bb0330","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/jcb.23123","article-title":"The mouse RANKL gene locus is defined by a broad pattern of histone H4 acetylation and regulated through distinct distal enhancers","volume":"112","author":"Martowicz","year":"2011","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bone.2012.08.121_bb0335","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1210\/en.2007-0734","article-title":"Targeted deletion of a distant transcriptional enhancer of the receptor activator of nuclear factor-\u03baB ligand gene reduces bone remodeling and increases bone mass","volume":"149","author":"Galli","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2012.08.121_bb0340","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1210\/me.2011-1149","article-title":"The RANKL distal control region is required for the increase in RANKL expression, but not the bone loss, associated with hyperparathyroidism or lactation in adult mice","volume":"26","author":"Onal","year":"2012","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.bone.2012.08.121_bb0345","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1359\/jbmr.2000.15.5.863","article-title":"In vivo demonstration that human parathyroid hormone 1\u201338 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene","volume":"15","author":"Onyia","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2012.08.121_bb0350","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1359\/jbmr.2002.17.9.1667","article-title":"Cyclic adenosine monophosphate\/protein kinase A mediates parathyroid hormone\/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells","volume":"17","author":"Kondo","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2012.08.121_bb0355","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1359\/JBMR.0301226","article-title":"PTH differentially regulates expression of RANKL and OPG","volume":"19","author":"Huang","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2012.08.121_bb0360","first-page":"115","article-title":"Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bone.2012.08.121_bb0365","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2007.07.025","article-title":"Estrogen prevents bone loss via estrogen receptor \u03b1 and induction of Fas ligand in osteoclasts","volume":"130","author":"Nakamura","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bone.2012.08.121_bb0370","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1210\/me.2009-0354","article-title":"The estrogen receptor-\u03b1 in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone","volume":"24","author":"Martin-Millan","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.bone.2012.08.121_bb0375","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","article-title":"Role of RANK ligand in mediating increased bone resorption in early postmenopausal women","volume":"111","author":"Eghbali-Fatourechi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2012.08.121_bb0380","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2009.05.024","article-title":"Orchiectomy upregulates free soluble RANKL in bone marrow of aged rats","volume":"45","author":"Proell","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bone.2012.08.121_bb0385","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bone.2009.06.011","article-title":"Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin","volume":"45","author":"Li","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bone.2012.08.121_bb0390","first-page":"3128","article-title":"The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone","volume":"82","author":"Tomkinson","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2012.08.121_bb0395","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bone.2009.11.006","article-title":"Osteocyte apoptosis and control of bone resorption following ovariectomy in mice","volume":"46","author":"Emerton","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.bone.2012.08.121_bb0400","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1359\/jbmr.081210","article-title":"Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue","volume":"24","author":"Cardoso","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2012.08.121_bb0405","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1359\/jbmr.060107","article-title":"Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss","volume":"21","author":"Aguirre","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2012.08.121_bb0410","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S8756-3282(01)00642-1","article-title":"Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression","volume":"30","author":"Parfitt","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.bone.2012.08.121_bb0415","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.bone.2012.01.025","article-title":"Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations","volume":"50","author":"Kennedy","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.bone.2012.08.121_bb0420","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1359\/jbmr.080207","article-title":"Apoptotic bodies convey activity capable of initiating osteoclastogenesis and localized bone destruction","volume":"23","author":"Kogianni","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2012.08.121_bb0425","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1074\/jbc.M705092200","article-title":"Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost\/sclerostin","volume":"283","author":"Robling","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2012.08.121_bb0430","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/bbrc.1997.7404","article-title":"A new mechanism of bone destruction in rheumatoid arthritis: synovial fibroblasts induce osteoclastogenesis","volume":"240","author":"Takayanagi","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bone.2012.08.121_bb0435","first-page":"943","article-title":"Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis","volume":"152","author":"Gravallese","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bone.2012.08.121_bb0440","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P","article-title":"Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor","volume":"43","author":"Gravallese","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bone.2012.08.121_bb0445","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbrc.2012.02.099","article-title":"Mechanical loading prevents the stimulating effect of IL-1\u03b2 on osteocyte-modulated osteoclastogenesis","volume":"420","author":"Kulkarni","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bone.2012.08.121_bb0450","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1002\/art.24920","article-title":"Tumor necrosis factor \u03b1 and interleukin-1\u03b2 modulate calcium and nitric oxide signaling in mechanically stimulated osteocytes","volume":"60","author":"Bakker","year":"2009","journal-title":"Arthritis Rheum"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328212011350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328212011350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:38:08Z","timestamp":1762659488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328212011350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S8756328212011350"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2012.08.121","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteocyte control of osteoclastogenesis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2012.08.121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}